Allergic Reactions

We recommend

holka_malá_dítě_logopedie_výslovnost_výuka_řeč_mluvení

Pharmacokinetics and Safety Profile of Bilastine in Patients Aged 6–11 Years –⁠ Findings from Post-hoc Analysis of Studies

4. 3. 2020 Source: Allergic Reactions

The second-generation antihistamine bilastine is approved in Europe for the treatment of allergic rhinoconjunctivitis and urticaria in children over 6 years old. Post-hoc analyses of two clinical studies focused on its safety profile and pharmacokinetics in the pediatric population.

Bilastine and its role in the treatment of allergic rhinoconjunctivitis and urticaria in children

The prevalence of allergic rhinitis (AR) in the pediatric population is estimated worldwide at…

10. 6. 2022 Source: Allergic Reactions

Indication of Bilastine in Specific Patient Groups −⁠ Practical Tips for Clinical Practice

Bilastine is a non-sedating H1-antihistamine, which is very well tolerated by patients. It can be…

24. 5. 2022 Source: Allergic Reactions

Articles on this topic

Bilastine in the treatment of allergic rhinitis –⁠ meta-analysis shows advantage of lower somnolence

A newly published systematic review and meta-analysis evaluate the efficacy and safety of…

24. 5. 2022 Source: Allergic Reactions

Nasal Smear as a Modern and Gentle Diagnostic Method for Allergic Rhinitis

Up to 130 million Europeans suffer from allergic rhinitis. Until now, standard diagnostic…

14. 10. 2021 Source: Allergic Reactions

Impact of Chronic Urticaria on Patients' Quality of Life and Society

An international team of dermatologists has mapped out the impact of chronic urticaria on…

25. 8. 2021 Source: Allergic Reactions

Bilastine as a reliable helper in the treatment of allergic rhinoconjunctivitis and urticaria even in younger children

Until recently, bilastine was indicated for the treatment of allergic rhinoconjunctivitis and…

21. 7. 2021 Source: Allergic Reactions

Dynamics of Allergy Development in Children

The prevalence of allergic diseases in children in developed countries has been steadily…

1. 10. 2020 Source: Allergic Reactions

Use of Bilastine in Pediatrics −⁠ Pathway to Improving Concentration and Performance of Young Allergy Sufferers

In the treatment of allergic diseases, especially in children, safety, good tolerability,…

1. 10. 2020 Source: Allergic Reactions

Pharmacokinetics and Safety of Bilastine 10 mg in Children Aged 6–11 Years

The second-generation antihistamine bilastine is approved in Europe for the treatment of…

17. 8. 2020 Source: Allergic Reactions

Safety and Tolerability of Bilastine in the Treatment of Chronic Urticaria in Children

Chronic urticaria is less common in pediatric patients compared to the acute form, but it…

17. 8. 2020 Source: Allergic Reactions

Incidence of Allergic Diseases in Children Probably Unrelated to Air Pollution

A recently published extensive meta-analysis of 7 cohorts of children aged 4 and 8 from 5…

12. 6. 2020 Source: Allergic Reactions

Journal articles Exogenous allergic alveolitis in automobile industry –⁠ case report

2. 4. 2014 Source: Occupational Medicine | 1/2014

E-courses on this topic

Authors: MUDr. Jana Emlerová

Course detail

Conferences news

EAACI 2022: Co říkají aktuální poznatky o vlivu biodiverzity a zeleně na vznik alergií?

1. 7. 2022 - 3. 7. 2022

1 record

Go to records